Raleigh police are investigating after four men were shot near Trawick Road overnight.
Raleigh police are investigating after four men were shot near Trawick Road overnight.
Virgin Money stocks slid as it became the latest bank to set aside more cash for feared credit losses, in a sign of lenders’ concerns over the economic outlook for the UK.
The restrictions, which will start late on Friday, are aimed at preventing a strained health system from being overwhelmed and at halting the spread of infections in the Balkan country of 7 million people. Like much of central and eastern Europe, Bulgaria weathered the first wave of the COVID-19 pandemic relatively well in the spring, but cases have spiked across the region this autumn. Bulgaria registered 4,382 new infections on Wednesday, bringing the total number to 129,348.
Ed Murray, eldest brother of Bill Murray and the man who provided the inspiration for the movie Caddyshack, has died.
The "Global Fingerprint Sensors Market, 2020" report has been added to ResearchAndMarkets.com's offering.
The latest Walmart TV deals for Black Friday, including the latest top-rated 4K and smart TV sales
Check out our comparison of the top Coach Outlet deals for Black Friday 2020, featuring the latest sales on Coach luxury handbags, watches & purses
TORONTO, Nov. 25, 2020 (GLOBE NEWSWIRE) -- FreshBooks, the 2 small business accounting software in America with paying customers in 100+ countries, announced that it has partnered with Barclays to bring joint solutions to UK customers in an effort to help small business owners in the UK on a larger scale. The two organizations are working on innovative approaches to invoicing and business management, and will integrate Barclaycard Payments solutions into FreshBooks’ award-winning cloud invoicing and accounting platform. Nicole Olbe, Managing Director of Partnerships at Barclaycard Payments, said: “Our goal is to develop best-in-class payment solutions to help our clients grow, and integrating with FreshBooks’ award-winning platform offers us a fantastic new avenue to achieve that. We look forward to sharing more information about this exciting partnership in 2021.”FreshBooks customers in the UK already have access to a recently-released suite of features to help small business owners independently manage their day-to-day, including: * Making Tax Digital: To assist UK business owners during tax time, FreshBooks has launched FreshBooksMTD, which provides an easy-to-use tax filing integration compliant with the UK’s government-mandated VAT filing regulations for small businesses. Customers’ VAT returns are automatically populated based on digital invoice and transaction history, and can be filed from within the customer’s FreshBooks account within a few clicks. * Mileage Tracker: The new mileage tracker feature allows business owners to automatically track their mileage on the FreshBooks iOS app to aid in accurate billing. With one swipe, users can categorize trips as personal or business-related, and can also view an estimate of their potential tax deductions at any time. * Direct Debit: This option allows business owners to accept invoice payments from their clients via bank transfer, and provides the option to automate the invoice reconciliation process or store direct debit information for clients to collect recurring payments. “Above all else, FreshBooks prides itself on being software that is built for owners,” said Mike McDerment, CEO and Co-Founder of FreshBooks. "With the release of recent UK-specific features like Direct Debit and FreshBooksMTD, we’re excited to deliver more ways for business owners in the UK to easily manage their day-to-day business needs, all from within FreshBooks.”According to the UK’s Federation of Self Employed & Small Businesses, the number of small businesses in the UK is growing 3% per year, on average. There were 5.94 million small businesses at the beginning of 2020, which is an increase of 2.4% compared to the previous year. SMEs account for three fifths of the employment, while total employment in SMEs stands at 16.6 million people. According to a report from Simply Business, despite the COVID-19 pandemic, 85% of small business owners intend to remain self-employed.Last year, FreshBooks partnered with telecommunications and mobile service provider Three UK, where FreshBooks is a key partner of Three Means Business, a mobile offering designed to meet the needs of small business owners and entrepreneurs. Recently, FreshBooks has continued to accelerate its growth in the UK market by launching an ad campaign targeted to UK-based business owners.About FreshBooks FreshBooks is the 2 small business accounting software in America, with paying customers in 100+ countries around the world. The company has helped more than 24 million people process billions of dollars through its easy-to-use invoicing, time-tracking, expense management, and online payments features. Recognized with 10 Stevie awards for the best customer service in the world, the company’s mantra is to “execute extraordinary experiences everyday.” FreshBooks is headquartered in Toronto, Canada, with offices in San Luis Potosi, Mexico, Amsterdam, Netherlands, and Raleigh, North Carolina, USA. Learn more at www.FreshBooks.comContact: Katey Townshend FreshBooks email@example.com
The "Ambulatory Surgery Centers Market by Product, By Component, By Specialty Type, and By Geography - Global Drivers, Restraints, Opportunities, Trends, and Forecast up to 2026" report has been added to ResearchAndMarkets.com's offering.
Global Spatial Genomics and Transcriptomics Market to Reach $2,173. 0 Million by 2030. Market Report Coverage - Spatial Genomics and Transcriptomics.New York, Nov. 25, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Spatial Genomics and Transcriptomics Market: Focus on Product Type, Sample Type, Workflow, Application, End User, Region and Competitive Landscape - Analysis and Forecast, 2020-2030" - https://www.reportlinker.com/p05989635/?utm_source=GNW Market Segmentation • Product Type – Kits and Assays, Instruments, Software, and Services • Sample Type – Fresh Frozen Tissues, Fixed Frozen Tissues, Fixed-Formalin Paraffin Embedded Tissues, and Cultured Cells • Workflow – Spatial Imaging, Spatial Analysis, and Spatial Sequencing • Application- Diagnostics, Drug Discovery and Development, Translational Research, Single-Cell Analysis, Cell Biology and Others • End User –Academic and Research Institutions, Biopharmaceutical and Biotechnological Companies, Contract Research Organizations and Other End Users Regional Segmentation • North America – U.S., Canada • Europe – Germany, France, Italy, U.K., Spain, and Rest-of-Europe • Asia-Pacific – China, Japan, India, Singapore, Australia, and Rest-of-Asia-Pacific (RoAPAC) • Latin America – Brazil, Mexico, and Rest-of-the-Latin America • Rest-of-the-World Growth Drivers • Increasing Prevalence of Various Types of Genetic Disorders Globally • Technological Advancements in Sequencing Technologies • Increasing Research Funding in the Field of Spatial Transcriptomics Market Challenges • High Capital Requirement Hampering the Expansion of Global Reach • Lack of Tools for Computational Analysis Market Opportunities • Opportunity (by Product) • Opportunity (by Technology) • Expansion into New Research Application such as Spatial Metagenomics • Expansion into Emerging Markets Key Companies Profiled NanoString Technologies, Inc., S2 Genomics, Inc., Flagship Biosciences, Inc., Akoya Biosciences, Inc. RareCyte, Inc., IONpath, Inc., Fluidigm Corporation, 10x Genomics, Inc., Visikol, Inc., Miltenyi Biotec, and BioSpyder Technologies Key Questions Answered in this Report: • What are the major market drivers, challenges, and opportunities in the global spatial genomics and transcriptomics market? • What is the potential impact of biotechnological advancement in the diagnostic industry among the end users, such as researchers, pathologists, and laboratory technicians? • What is the current market demand along with future expected demand for the global spatial genomics and transcriptomics market? • How have spatial profiling helped cellular imaging and visualization to become a prominent tool for diagnostics in various clinical applications? • What are the key development strategies which are implemented by the major players in order to sustain in the competitive market? • How is each segment of the market expected to grow during the forecast period from 2020 to 2030 based each on segment? Following are each segment type: o product type o sample type o workflow o application o end user o region, namely, North America, Europe, Asia-Pacific, Rest-of-the-World (ROW) • Who are the leading players with significant offerings to the global spatial genomics and transcriptomics market? What is the expected market dominance for each of these leading players? • Which emerging companies are anticipated to be highly disruptive in the future, and what are their key strategies for sustainable growth in the global spatial genomics and transcriptomics market? Market Overview Healthcare experts have found the spatial genomics and transcriptomics market to be one of the most rapidly evolving markets, which is predicted to grow at a CAGR of 23.20% during the forecast period of 2020-2030. The market is driven by certain factors, which include the increasing prevalence of various types of genetic disorders, such as cancer, neurological disorder, and rare diseases, inciting the development of high-resolution multiplex assays and instruments, technological advancements in sequencing technologies, and significant research funding in the field of spatial-based technology for executing R&D exercises. The market is favored by the development of spatial profiling-based solutions for visualization and analysis of tissue microenvironment, tumor biology, and tissue biomarker. The gradual increase in the prevalence of neurological disorders and rare diseases globally has furthered the spatial genomics and transcriptomics market. Furthermore, several contract research organizations are focusing on the development of spatial profiling-based services, which enables simultaneous in-situ spatial analysis of multiple biomarkers proteins or more than a hundred mRNAs from single formalin-fixed paraffin-embedded (FFPE) tissue or frozen tissue section. Within the research report, the market is segmented on the basis of product type, sample type, workflow, application, end users, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained. Competitive Landscape The exponential rise in the application of precision medicine on the global level has created a buzz among companies to invest in the development of high-resolution multiplex diagnostics providing information on cellular interaction and tissue heterogeneity to understand disease biology and pathology. Due to technologically advanced solutions and intense market penetration, BioTechne Corporation has been a pioneer in this field and has been a significant competitor in this market. Other key players in the market are NanoString Technologies, Inc., S2 Genomics, Inc., Flagship Biosciences, Inc., Akoya Biosciences, Inc. RareCyte, Inc., IONpath, Inc., Fluidigm Corporation, 10x Genomics, Inc., Visikol, Inc., Miltenyi Biotec, and BioSpyder Technologies. On the basis of region, North America holds the largest share of spatial genomics and transcriptomics market due to improved healthcare infrastructure, rise in per capita income, and availability of state-of-the-art research laboratories and institutions in the region. Apart from this, Europe region is anticipated to grow at the fastest CAGR of 23.54% during the forecast period 2020-2030. The market utilizes several technologies, such as barcoding, sequencing, mass cytometry, and microscopy, for the development of instruments and assay for spatial profiling of tissue section to gain an understanding of tissue microenvironment. Each solution offered by the leading players is the combination of next-generation omics tools for application in several clinical areas, such oncology, neurology, immunology, and pathology. Countries Covered • North America • U.S. • Canada • Europe • Germany • France • Spain • U.K. • Italy • Rest-of-Europe • Asia-Pacific • China • India • Singapore • Australia • Japan • Rest-of-Asia-Pacific • Latin America • Brazil • Mexico • Rest-of-Latin America • Rest-of-the-World Read the full report: https://www.reportlinker.com/p05989635/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ CONTACT: Clare: firstname.lastname@example.org US: (339)-368-6001 Intl: +1 339-368-6001
The Blinding Lights singer was expected to perform strongly, but didn't get any nominations.
Dublin, Nov. 25, 2020 (GLOBE NEWSWIRE) -- The "Chronic Pain Treatment Market Research Report: By Product, Indication, Application, Distribution Channel, End User - Global Industry Analysis and Growth Forecast to 2030" report has been added to ResearchAndMarkets.com's offering. The global chronic pain treatment market is predicted to progress at a CAGR of 6.5% from 2020 to 2030 and generate a revenue of $151.7 billion in 2030. The factors fueling the expansion of the market are the rising implementation of favorable policies by various governments, soaring geriatric population and the subsequent rise in the need for elderly care, and the growing incidence of chronic diseases across the world. The drugs category is further divided into NSAIDs (non-steroidal anti-inflammatory drugs), opioids, antidepressants, and anticonvulsants. Out of these, the opioids are predicted to register the highest growth in the chronic pain treatment market in the upcoming years, on account of the extensive utilization of these drugs for relieving pain, reducing sprains and strains and inflammation, and reducing the body temperature. On the other hand, the devices category is classified into ablation devices, analgesic infusion pumps, and neurostimulation devices. Amongst these, the neurostimulation devices category registered the highest growth in the market in the years gone by. This was due to the high public awareness about these devices in various countries and the high popularity of these devices among both patients and doctors around the world. Globally, the chronic pain treatment market recorded the highest growth in North America during the past few years and this trend would continue in the forthcoming years as well. This would be a result of the growing geriatric population, the existence of several chronic pain management medicines and devices and the rising prevalence of chronic diseases in the region. The players operating in the chronic pain treatment market are increasingly focusing on product launches for gaining foothold in the market. For example, the FDA approved Voltaren Arthritis Pain, which has been recently developed by GlaxoSmithKline plc, in February 2020. This product provides temporary relief to the patient from arthritis pain and is suitable for people in the age group 18 years and above. The FDA approval made this product the first prescription-strength NSAID topical gel for arthritis pain available OTC in the U.S. Key Topics Covered: Chapter 1. Research Background 1.1 Research Objectives 1.2 Market Definition 1.3 Research Scope 1.4 Key StakeholdersChapter 2. Research Methodology 2.1 Secondary Research 2.2 Primary Research 2.3 Market Size Estimation 2.4 Data Triangulation 2.5 Assumptions for the StudyChapter 3. Executive SummaryChapter 4. Introduction 4.1 Definition of Market Segments 4.1.1 By Product 22.214.171.124 Drugs 126.96.36.199.1 Opioids 188.8.131.52.2 NSAIDs 184.108.40.206.3 Anticonvulsants 220.127.116.11.4 Antidepressants 18.104.22.168.5 Others 4.1.2 By Devices 22.214.171.124 Neurostimulation devices 126.96.36.199.1 SCS 188.8.131.52.2 TENS 184.108.40.206.3 Others 220.127.116.11 Analgesic infusion pumps 18.104.22.168 Ablation devices 22.214.171.124.1 Radiofrequency ablation devices 126.96.36.199.2 Cryoablation devices 4.1.3 By Indication 188.8.131.52 Neuropathic pain 184.108.40.206 Arthritis pain 220.127.116.11 Chronic back pain 18.104.22.168 Cancer pain 22.214.171.124 Migraine 126.96.36.199 Fibromyalgia 188.8.131.52 Others 4.1.4 By Application 184.108.40.206 Musculoskeletal 220.127.116.11 Neuropathy 18.104.22.168 Oncology 22.214.171.124 Others 4.1.5 By Distribution channel 126.96.36.199 Direct 188.8.131.52 Indirect 4.1.6 By End User 184.108.40.206 Hospitals 220.127.116.11 Clinics 18.104.22.168 Nursing homes 22.214.171.124 Research centers & universities 126.96.36.199 Others 4.2 Market Dynamics 4.2.1 Trends 188.8.131.52 Innovations in the field of pain management 184.108.40.206 Increasing number of product approvals 4.2.2 Drivers 220.127.116.11 Increasing government support for chronic pain management 18.104.22.168 Growing geriatric population 22.214.171.124 Surging prevalence of chronic health conditions 126.96.36.199 Impact analysis of drivers on market forecast 4.2.3 Restraints 188.8.131.52 Side effects associated with pain management drugs and devices 184.108.40.206 Product recalls 220.127.116.11 Patent expiry of blockbuster chronic pain treatment drugs 18.104.22.168 Increasing usage of opioids and antidepressants 22.214.171.124 Impact analysis of restraints on market forecast 4.2.4 Opportunities 126.96.36.199 Untapped markets in developing economies 4.3 Porter's Five Forces Analysis 4.4 Impact of COVID-19Chapter 5. Industry Insights 5.1 Epidemiological Analysis of Chronic Pain Indications 5.1.1 North America 5.1.2 Europe 5.1.3 Japan 5.1.4 China 5.2 Pricing and Reimbursement Scenario 5.2.1 Pricing 5.2.2 Reimbursement Scenario 188.8.131.52 U.S. 184.108.40.206 Europe 220.127.116.11 Japan 5.3 Research Funding and Government Initiatives 5.4 Pipeline Drugs for Chronic Pain 5.5 Key Products Expected to be Launched 5.6 TreatmentChapter 6. Global Market Size and Forecast 6.1 By Product 6.1.1 Chronic Pain Drugs Market, by Type 6.1.2 Chronic Pain Devices Market, by Type 18.104.22.168 Neurostimulation devices market for chronic pain treatment, by type 22.214.171.124 Ablation devices market for chronic pain treatment, by type 6.2 By Indication 6.3 By Application 6.4 By Distribution Channel 6.5 By End User 6.6 By RegionChapter 7. North America Market Size and ForecastChapter 8. Europe Market Size and ForecastChapter 9. APAC Market Size and ForecastChapter 10. LATAM Market Size and ForecastChapter 11. MEA Market Size and ForecastChapter 12. Competitive Landscape 12.1 Product Benchmarking of Key Players 12.2 Global Strategic Developments of Key PlayersChapter 13. Company Profiles 13.1 Business Overview 13.2 Product and Service Offerings 13.2.1 Marketed products 13.2.2 Pipeline products 13.3 Key Financial Summary * Eli Lilly and Company * GlaxoSmithKline plc * Pfizer Inc. * Medtronic plc * Abbott Laboratories * Boston Scientific Corporation * Novartis AG * Johnson & Johnson * AstraZeneca plc * Bristol-Myers Squibb Company * Becton, Dickinson and Company * Sanofi S.A.For more information about this report visit https://www.researchandmarkets.com/r/zf691k Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Leading shareholders of German retail group Metro are in talks on a joint proposal for a future chairman in a sign that they are working to put a long-lasting spat behind them, three people close to the matter said. Czech billionaire Daniel Kretinsky secured more than 40% of Metro's voting rights after an unsolicited voluntary offer of his vehicle EPGC expired last week. Kretinsky failed in several attempts to buy the stakes of the foundations, which said his offer price was two low.
With just days to go until the main event, here’s all the best early deals to shop now
17LIVE, Inc. today announced that Hirofumi Ono, Global CEO of 17LIVE Inc., which operates a live-streaming business worldwide, has been invited to speak at the world's largest technology conference - Web Summit 2020 - scheduled from December 2 to 4, 2020.
‘Meeting other mums helped me find a way through the trauma’
Turkey's President Tayyip Erdogan said on Wednesday he discussed in a phone call with Russia's Vladimir Putin the possibility of expanding efforts to maintain the Nagorno-Karabakh ceasefire to include other regional countries. The ceasefire signed on Nov. 10 halted military action in and around Nagorno-Karabakh, internationally recognised as part of Azerbaijan but populated by ethnic Armenians, after the worst fighting in the region since the 1990s.
Save on swing set deals at the Black Friday 2020 sale, together with more backyard play set discounts
Cyber Monday mirrorless camera deals for 2020 have arrived, compare the best Cyber Monday Nikon, Canon, Sony Alpha, Fujifilm and Pentax deals listed
Review of all the latest Canada Goose deals for Black Friday, featuring discounts on jackets, coats, vests, parkas, hats & more Here’s our list of the top Canada Goose deals for Black Friday 2020, including all the top discounts on raincoats, bombers, parkas, jackets, coats and more outerwear & accessories. Links to the best deals are listed below.Best Canada Goose Deals: * Shop the full range of Canada Goose jackets, parkas & coats on sale at CanadaGoose.com * Shop the latest Canada Goose men’s parkas, lightweight jackets, knitwear & more at CanadaGoose.com * Shop the wide range of Canada Goose women’s jackets, coats, parkas & more at CanadaGoose.com * Save up to $119 on Canada Goose apparel at Amazon.com \- find the best deals on parkas, coats, bomber jackets, hats, and more * Save up to $99 on Canada Goose jackets at Amazon \- including Women’s Rossclair, Men’s Expedition, Grizzly Bomber Jacket, Chateau, and more * Shop Save up to $100 on a wide range of parkas from Canada Goose now available at Amazon \- get the best deal on winter wear, including Women’s Chelsea Parka, Trillium Parka, Men’s Wyndham Parka, and more * Save on hats from Canada Goose and more at Amazon.com \- check the latest prices from top brands like Canada Goose, Zavelio, and moreIn need of some more deals? Click here to compare the entire selection of deals at Walmart’s Black Friday sale and click here to see Amazon’s current Black Friday deals. Consumer Walk earns commissions from purchases made using the links provided.Canada Goose winter clothing has often been seen in movies and magazines promoted by celebrities like Kate Upton. They have an entire jacket collection to suit every preference. The Men’s Chilliwack Bomber Jacket is a staple for colder months along with the Women’s Kensington Parka. A Canada Goose coat is made to withstand temperatures below 30 degrees further adding to its popularity.About Consumer Walk: Consumer Walk reports the latest online retail news. As an Amazon Associate and affiliate Consumer Walk earns from qualifying purchases.Contact: Andy Mathews (firstname.lastname@example.org)
Meghan Markle has revealed she suffered a miscarriage over the summer, and has called on people to be more empathetic with one another to combat "the danger of siloed living." In a New York Times op-ed titled "The Losses We Share" published early Wednesday, Markle wrote of an ordinary July morning that quickly turned nightmarish […]